CVS HEALTH CORPORATION (CVS) FY2023 Annual Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2023-12-31

Swipe to see the full flow
CVS HEALTH CORPORATION (CVS) FY2023 Annual Balance SheetBalance sheet as of 2023-12-31. The chart shows assets, liabilities and equity at that date.Current liabilities$79.19 BCurrent assets$67.86 BLiabilities$173.09 BAssets$249.73 BNon-current assets$181.87 BNon-current liabilities$93.90 BEquity$76.64 BGross equity(calculated)$110.77 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivable, netInventoriesCash and cash equivalentsInvestmentsOther current assetsGoodwillIntangible assets, netLong-term investmentsOperating lease right-of-use assetsProperty and equipment, netOther assetsSeparate accounts assetsPharmacy claims and discounts payableAccrued expensesAccounts payableHealth care costs payableCurrent portion of long-term debtCurrent portion of operating lease liabilitiesPolicyholders’ fundsOther insurance liabilitiesShort-term debtLong-term debtLong-term operating lease liabilitiesOther long-term liabilitiesOther long-term insurance liabilitiesDeferred income taxesSeparate accounts liabilitiesRetained earningsCommon stock, par value $0.01: 3,200 shares authorized; 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplusNoncontrolling interestsCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock, at cost: 480 and 458 shares at December 31, 2023 and 2022Accumulated other comprehensive lossPharmacy claims and discounts payablePharmacy claims and discounts payable$22.87 BAccrued expensesAccrued expenses$22.19 BAccounts payableAccounts payable$14.90 BCurrent liabilitiesCurrent liabilities$79.19 BHealth care costs payableHealth care costs payable$12.05 BAccounts receivable, netAccounts receivable, net$35.23 BCurrent assetsCurrent assets$67.86 BCurrent portion of long-term debtCurrent portion of long-term debt$2.77 BInventoriesInventories$18.03 BLiabilitiesLiabilities$173.09 BCurrent portion of operating lease liabilitiesCurrent portion of operating lease liabilities$1.74 BCash and cash equivalentsCash and cash equivalents$8.20 BAssetsAssets$249.73 BPolicyholders’ fundsPolicyholders’ funds$1.33 BInvestmentsInvestments$3.26 BOther insurance liabilitiesOther insurance liabilities$1.14 BOther current assetsOther current assets$3.15 BShort-term debtShort-term debt$200.00 MNon-current assetsNon-current assets$181.87 BGoodwillGoodwill$91.27 BLong-term debtLong-term debt$58.64 BNon-current liabilitiesNon-current liabilities$93.90 BLong-term operating lease liabilitiesLong-term operating lease liabilities$16.03 BIntangible assets, netIntangible assets, net$29.23 BEquityEquity$76.64 BOther long-term liabilitiesOther long-term liabilities$6.21 BLong-term investmentsLong-term investments$23.02 BOther long-term insurance liabilitiesOther long-term insurance liabilities$5.46 BOperating lease right-of-use assetsOperating lease right-of-use assets$17.25 BDeferred income taxesDeferred income taxes$4.31 BProperty and equipment, netProperty and equipment, net$13.18 BSeparate accounts liabilitiesSeparate accounts liabilities$3.25 BGross equity (calculated)Gross equity(calculated)$110.77 BOther assetsOther assets$4.66 BSeparate accounts assetsSeparate accounts assets$3.25 BRetained earningsRetained earnings$61.60 BCommon stock, par value $0.01: 3,200 shares authorized; 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplusCommon stock and capital surplus$48.99 BNoncontrolling interestsNoncontrolling interests$175.00 MTreasury stock, at cost: 480 and 458 shares at December 31, 2023 and 2022Treasury stock−$33.84 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$297.00 M
Chart details

CVS HEALTH CORPORATION (CVS) FY2023 Annual Balance Sheet

Balance sheet as of 2023-12-31. The chart shows assets, liabilities and equity at that date.

Assets
249,728,000,000 US dollars
Current assets
67,858,000,000 US dollars
Non-current assets
181,870,000,000 US dollars
Liabilities
173,092,000,000 US dollars
Current liabilities
79,189,000,000 US dollars
Non-current liabilities
93,903,000,000 US dollars
Equity
76,636,000,000 US dollars
Noncontrolling interest
175,000,000 US dollars. Included in consolidated equity; this amount is not added again.
Accounts receivable, net
35,227,000,000 US dollars
Inventories
18,025,000,000 US dollars
Cash and cash equivalents
8,196,000,000 US dollars
Investments
3,259,000,000 US dollars
Other current assets
3,151,000,000 US dollars
Assets held for sale
0 US dollars
Goodwill
91,272,000,000 US dollars
Intangible assets, net
29,234,000,000 US dollars
Long-term investments
23,019,000,000 US dollars
Operating lease right-of-use assets
17,252,000,000 US dollars
Property and equipment, net
13,183,000,000 US dollars
Other assets
4,660,000,000 US dollars
Separate accounts assets
3,250,000,000 US dollars
Pharmacy claims and discounts payable
22,874,000,000 US dollars
Accrued expenses
22,189,000,000 US dollars
Accounts payable
14,897,000,000 US dollars
Health care costs payable
12,049,000,000 US dollars
Current portion of long-term debt
2,772,000,000 US dollars
Current portion of operating lease liabilities
1,741,000,000 US dollars
Policyholders’ funds
1,326,000,000 US dollars
Other insurance liabilities
1,141,000,000 US dollars
Short-term debt
200,000,000 US dollars
Liabilities held for sale
0 US dollars
Long-term debt
58,638,000,000 US dollars
Long-term operating lease liabilities
16,034,000,000 US dollars
Other long-term liabilities
6,211,000,000 US dollars
Other long-term insurance liabilities
5,459,000,000 US dollars
Deferred income taxes
4,311,000,000 US dollars
Separate accounts liabilities
3,250,000,000 US dollars
Retained earnings
61,604,000,000 US dollars
Common stock, par value $0.01: 3,200 shares authorized; 1,768 shares issued and 1,288 shares outstanding at December 31, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus
48,992,000,000 US dollars
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding
0 US dollars
Noncontrolling interests
175,000,000 US dollars
Treasury stock, at cost: 480 and 458 shares at December 31, 2023 and 2022
negative 33,838,000,000 US dollars
Accumulated other comprehensive loss
negative 297,000,000 US dollars
Gross equity (calculated)
110,771,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
CVS HEALTH CORPORATION (CVS) FY2023 Annual Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!